Skip to main content

Genetics Medicine

The Medicine Genetics Group of the VHIR belongs to the Clinical and Molecular Genetic Area of the Hospital Vall d'Hebron and combines genetic diagnosis and translational research in hereditary diseases and the study of pathologies and malformations during human development. The group actively works in different consortiums and networks for rare disorders including ERN Ithaca, Cranio, Bond, VASCERN and NMD; SMA Europe; XUEC malalties cognitiu conductuals edat pediàtrica, CIBERER.

eCORE

  • Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health
  • Woman & Child Health & Rare Diseases

Team

Group Leader
Eduardo Fidel Tizzano Ferrari

Principal Investigator (PI)
Plaja Rustein, Alberto ; Antolin Mate, María; Cueto González Anna M; Abuli Vidal Anna; Codina Sola Marta; Castells Sarret Neus; Berta Campos Estela, Mar Xunclá

Researchers
Mar Costa Roger, Nuria Martínez Gil (Juan de la Cierva), Jordi Leno Colorado, Alejandro Moles, Rovira Moreno, Eulalia; Patricia Muñoz Cabello, Natalia Rey Viñets

PhD Students
Barranco Bartolomé, Paula (AGAUR-Doctorado Industrial) ; Blasco Pérez, Laura (lectura y defensa tesis doctoral Junio de 2023 UAB) ; Fernandez Alvarez, Paula, Georg Lindner; Laura Trujillano Lidon; Irene Valenzuela Palafol; Amaia Lasa Aranzasti

Publications

40
Publications
50.0
%Q1
255.80
Impact Factor
6.40
Average Impact Factor

Codina-Solà M, Trujillano L, Abulí A, Rovira-Moreno E, Muñoz-Cabello P, Campos B, Fernández-Álvarez P, Palau D, Carrasco E, Valenzuela I, Cueto-González AM, Lasa-Aranzasti A, Limeres J, Leno-Colorado J, Costa-Roger M, Moles-Fernández A, Balmaña J, Díez O, Cuscó I, Garcia-Arumí E, Tizzano EF
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history
Eur J Hum Genet. 2023 Feb;31(2):223-230.
DOI: 10.1038/s41431-022-01240-5
IF: 5.2

Abiusi E, Costa-Roger M, Bertini ES, Tiziano FD, Tizzano EF; all participants.
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands.
Neuromuscul Disord. 2024 Jan;34:114-122
DOI: 10.1016/j.nmd.2023.12.008
IF: 2.8

Blasco-Pérez L, Iranzo-Nuez L, López-Ortega R, Martínez-Cruz D, Camprodon-Gómez M, Tenés A, Antolín M, Tizzano EF, García-Arumí E
An Integral Approach to the Molecular Diagnosis of Tuberous Sclerosis Complex: The Role of Mosaicism and Splicing Variants
J Mol Diagn. 2023 Sep;25(9):692-701
DOI: 10.1016/j.jmoldx.2023.06.006
IF: 5.341

Abulí A, Costa-Roger M, Codina-Solà M, Valenzuela I, Leno-Colorado J, Rovira-Moreno E, Cueto-González A, Fernández-Álvarez P, García-Arumí E, Cuscó I, Tizzano EF
Experience using singleton exome sequencing of probands as an approach to preconception carrier screening in consanguineous couples
J Med Genet. 2023 Jun;60(6):540-546
DOI: 10.1136/jmg-2022-108607
IF: 4

Rovira-Moreno E, Abuli A, Muñoz P, Codina M, Bayes E, de Lemus M, Darras B, Tizzano E.F
The diagnosis communication process in spinal muscular atrophy: a cross-cutting view of the new challenges facing the therapeutic era
Genetics in Medicine Open 2023
DOI: 10.1016/j.gimo.2023.100825.
IF: 8.8

Projects

Aproximación genómica en atrofia muscular espinal (AME): estudio de casos especiales de pacientes con AME-5q y caracterización de pacientes con AME-no-5q
Principal Investigator: Eduardo Tizzano
Agency: ERDF funds
Funding: 159,720 €
Period: 2019-2021

Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects ‘SMABEYOND’
Principal Investigator: Eduardo Tizzano
Agency: European Commission
Funding: 250,904.88 €
Period: 2020-2024

Detección de factores genéticos estructurales modificadores del fenotipo en una población con defectos congénitos
Principal Investigator: Alberto Plaja Rubstein; Co-IP: Anna Mª Cueto-González
Agency: ERDF funds
Funding: 123,420 €
Period: 2020-2022

Estudio de los receptores adenosinérgicos para el desarrollo de terapias en Fibrosis Quística
Principal Investigator: Eduardo Tizzano, Elena García Arumí
Agency: Doctorado industrial AGAUR
Funding: 38,000€/year
Period: 2020-2023

Investigación de marcadores de Metiloma en pacientes con sospecha de enfermedades raras
Principal Investigator: Eduardo Tizzano
Agency: ISCIII
Funding: 1,518,500 €
Period: 2022-2024

VHIR Annual Report 2023